Fusion inhibitors securing a future in HIV infection

Author：

ISSN： 1173-8324

Source： Inpharma, Vol.1, Iss.1277, 2001-01, pp. : 7-8

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

A Novel Antiretroviral Class (Fusion Inhibitors) in the Management of HIV Infection. Present Features and Future Perspectives of Enfuvirtide (T-20)

Current Medicinal Chemistry, Vol. 13, Iss. 20, 2006-08 ,pp. : 2369-2384

Bentham Science Publishers

Access to resources Recommend Favorite

The Current Status and Challenges in the Development of Fusion Inhibitors as Therapeutics for HIV-1 Infection

Current Pharmaceutical Design, Vol. 19, Iss. 10, 2013-03 ,pp. : 1810-1817

Bentham Science Publishers

Access to resources Recommend Favorite

HIV entry and fusion inhibitors

By Chantry David

Expert Opinion on Emerging Drugs, Vol. 9, Iss. 1, 2004-05 ,pp. : 1-7

Informa Healthcare

Access to resources Recommend Favorite

Entry and fusion inhibitors of HIV

By Rusconi Stefano Bulgheroni Elisabetta Citterio Paola

Expert Opinion on Therapeutic Patents, Vol. 14, Iss. 5, 2004-05 ,pp. : 733-748

Informa Healthcare

Access to resources Recommend Favorite

Inhibitors of HIV cellular fusion

By Turpin J.A. Howard O.Z.

Expert Opinion on Therapeutic Patents, Vol. 10, Iss. 12, 2000-12 ,pp. : 1899-1909

Informa Healthcare

Access to resources Recommend Favorite